SHM
GILD icon

Sagard Holdings Management’s Gilead Sciences GILD Stock Holding History

Sagard Holdings Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$12.3K Hold
111
– – 0.06% 73
2025
Q2 		$12.3K Buy
+111
New +$11.8K 0.03% 78

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sagard Holdings Management's GILD Position: Q3 2025 in Review

Sagard Holdings Management held its Gilead Sciences (GILD) position steady in Q3 2025 at 111 shares worth $12.3K. The position accounts for 0.06% of the portfolio, ranked #73.

Sagard Holdings Management first reported a position in GILD in Q2 2025 and has held it in 2 quarters since. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Sagard Holdings Management held 111 shares of Gilead Sciences worth $12.3K as of Q3 2025.
  • Sagard Holdings Management left its Gilead Sciences share count unchanged in Q3 2025.
  • Gilead Sciences made up 0.06% of Sagard Holdings Management's portfolio in Q3 2025, its #73 holding.
  • Sagard Holdings Management first reported a position in Gilead Sciences in Q2 2025 and has held it in 2 quarters since.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Sagard Holdings Management's 13F filing for Q3 2025, filed 14 Nov 2025.